Ivermectin for preventing and treating COVID-19
Emergencias. 2023 Oct;35(5):381-383.
doi: 10.55633/s3me/E029.2023.
[Article in
English,
Spanish]
Affiliations
- 1 Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, Wuerzburg, Alemania..
- 2 Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, Wuerzburg, Alemania.
- 3 Department of Nephrology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Alemania.
- 4 Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Alemania.
- 5 Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Duesseldorf, Düsseldorf, Alemania.
- 6 Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Alemania.
No abstract available
MeSH terms
-
COVID-19* / prevention & control
-
Humans
-
Ivermectin* / therapeutic use